Echocardiographic imaging provides real-time guidance during transcatheter patent ductus arteriosus (PDA) closure in extremely low birth weight (ELBW) infants.
| INTRODUC TI ON
Patent ductus arteriosus (PDA) accounts for 5%-10% of all congenital heart diseases and is more common in premature neonates. 1 Around half of premature infants with a birth weight <1 kg and a third <1.5 kg have a PDA at 72 hours of life. 2, 3 Hemodynamically significant PDAs increase morbidity and mortality, and odds for death are six times higher in premature infants with a persistent PDA. [4] [5] [6] [7] Until recently available treatment options for hemodynamically significant PDAs in premature neonates have been medical treatment or surgical ligation.
Transcatheter PDA closure is considered the procedure of choice in patients >4 kg, and there are decades of experience with this procedure in infants, children, and adults. 8, 9 Recently several centers have shown the safety and efficacy of transcatheter PDA closure in extremely low birth weight (ELBW) infants. [10] [11] [12] [13] [14] 
| PREPROCEDURE ECHOC ARDIOG R AM
Controversy exists among the medical community regarding optimal timing of PDA closure in ELBW infants. 2 However, once a hemodynamically significant PDA is identified, transcatheter PDA closure in ELBW infants is a treatment option in centers with experience.
10-15
The decision to perform and timing of transcatheter PDA closure in an ELBW infant takes place prior to the day of the procedure. The preprocedural echocardiogram on the day of the procedure focuses on identifying the size and type of PDA, familiarization of the echocardiographic windows required to image the PDA, and evaluation of cardiovascular structures potentially affected during the procedure.
PDA morphology is highly variable, but recent reclassification of PDA types has been suggested to include the type "F" PDA to describe the common PDA seen in ELBW infants. 17 The "F type"
PDAs in premature infants are typically long and tortuous without significant stenosis, similar to the ductus arteriosus seen during fetal life. 16 Evaluation of PDA size is critical to correct device choice. To The left pulmonary artery (LPA) and aortic arch are potentially affected after transcatheter PDA closure, and any stenosis prior to the procedure should be evaluated. 
| PROCEDUR AL ECHOC ARDIOG R AM
The 
| P OS TPRO CEDURE ECHO C ARD I OG R AM
Quick evaluation of potentially affected cardiovascular structures after transcatheter PDA closure is prudent. Evaluation of pericardial effusion, valves crossed during the procedure, systolic function, and evidence of elevated right ventricular systolic pressure can be performed in a timely manner as not to prolong the procedure further. A more detailed evaluation 1-6 hours after PDA closure is recommended specifically to evaluate postligation cardiac syndrome (PLCS). PLCS is characterized by hypotension requiring inotrope support and respiratory failure usually occurring 6-12 hours after the procedure, and is described in up to 40%-50% of surgical cases. 18 Variations in timing and protocol of echocardiographic evaluation of cardiovascular function after PDA closure exist. 18, 19 The function protocol should include evaluation of volume 
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